Looking Beyond Severe Hypertriglyceridemia when Diagnosing Adult-Onset Citrullinemia Type II. [PDF]
Truong TH +6 more
europepmc +1 more source
Les fibrates sont utilisés cliniquement pour traiter l'hypertriglycéridémie. Leurs actions sont médiées par le peroxisome proliferator activated receptor [alpha] (PPAR [alpha]), un récepteur nucléaire hautement exprimé dans le foie, qui régule l ...
Tremblay-Mercier, Jennifer
core
Trends in utilization and cost of triglyceride-lowering therapies among Medicare beneficiaries: An analysis from the Medicare part D database. [PDF]
Malkani K +10 more
europepmc +1 more source
Lipid-lowering therapy: Evidence and future perspective. [PDF]
Komiyama M, Wada H, Dan GA, Hasegawa K.
europepmc +1 more source
Correction to "Acute pancreatitis caused by severe hypertriglyceridemia in a 61-year-old man on a carnivore diet". [PDF]
europepmc +1 more source
Adjunctive Non-Disease-Modifying Therapies in Multiple Sclerosis: Immunometabolic, Neuroprotective and Remyelination-Oriented Approaches. [PDF]
Damiza-Detmer A, Głąbiński A.
europepmc +1 more source
Lipid lowering in coronary artery disease - not just statins. [PDF]
Han J, Masmanian E, Wang T, Chua TP.
europepmc +1 more source
A 35-Year-Old Woman With Recurrent Hypertriglyceridemia-Induced Pancreatitis in Pregnancy Managed With Fenofibrate and Plasmapheresis. [PDF]
Wang J, Lu Z, Zhou C.
europepmc +1 more source
Long-term safety and efficacy of oral bezafibrate use in dogs with hypertriglyceridemia. [PDF]
Castonguay-Poirier M +3 more
europepmc +1 more source
Review Article: Targeting Peroxisome Proliferator-Activated Receptors in Primary Biliary Cholangitis. [PDF]
Schattenberg JM +8 more
europepmc +1 more source

